It's 2020 and Santa is coming to town via technology, kids. Photo via MAGI·SPHERE

Christmas may look a little different this year, but that doesn't mean Santa isn't coming to town. While a family picture with Santa is a seasonal staple for your mantel, the CDC guidelines aren't exactly conducive to a photo on Kriss Kringle's lap. The recently debuted MAGI·SPHERE installation at Sugar Land Town Square is helping patrons interact with Santa in a safe way.

Mall Santas have long been the stars of holiday cards and Christmas movies. As shopping centers across America grappled with how to safely create holiday experiences, a slew of options and ideas were deployed to assuage shoppers. Some Santas have donned face shields, others wave to children from behind plexiglass, few are booking online experiences with retailers like Macy's, and many are taking this Christmas season off for health concerns.

Like many destinations around the U.S., Sugar Land Town Square pivoted to an untraditional holiday experience. The MAGI·SPHERE, located on the plaza deck, is a holographic snow globe that allows visitors to interact and share their holiday wishes with a 3D projection of Santa Claus in real-time. The installation was created by Flight School Studio, a Dallas-based creative team that specializes in interactive activations, and uses proprietary technology.

Santa's MAGI·SPHERE in Sugar Land Texaswww.youtube.com

"That's what we challenged them with. On a tough year when kids have been stuck at home, can you create a little bit of magic?" said Matt Ragan, a Sugar Land Town Square representative, of the partnership with Flight School Studio in an interview on "Houston Life."

The MAGI·SPHERE's Santa isn't just a scripted hologram—the Santa can interact and have a two-way dialogue similar to an in-person meet-and-greet. Flight School Studio deployed facial recognition software to create an animated holograph of Santa that captures the nuances and movements of a nearby actor's face. As the actor playing Santa watches a video feed of guests and communicates from a separate room, the animated avatar reflects his gestures.

"The use of emerging technology allows us to make storytelling and experiences much more extraordinary. This is especially impactful when re-inventing such a longstanding holiday tradition," says Brandon Oldenburg, chief creative officer of Flight School Studio, in a statement.

The MAGI·SPHERE is just a taste of the activations Flight School Studio plans on bringing to the center. The studio's forthcoming brick and mortar location is slated to open at Sugar Land Town Square in early 2021. The 9,000-square-foot space will blend physical sets with technologies, including projection mapping, augmented reality, 3D animation, haptics, motion tracking, lighting, and sound.

"We can't wait to show the world more of what we have in store, while also putting our home state of Texas and the Houston area at the forefront of both mixed reality and how the retail environment is being reimagined for the future," Oldenburg says in a press release.

Families can visit the MAGI·SPHERE through Dec. 24 by making an appointment online or using the on-site queuing system. Social distancing and face masks in common areas will be enforced throughout the experience.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.